Can Stem Cell Treatment Benefit Stroke Recovery?
The novel treatment did not meet primary endpoints, however it did reduce hospitalization, adverse outcomes, and death.
International Stroke Conference 2016
Pregnancy in Older Age Elevates Hemorrhagic Stroke Risk
Women with pregnancy at an advanced age had significantly higher rates of ischemic stroke, hemorrhagic stroke, myocardial infarction, and cardiovascular death.
Post-Stroke Bowel Obstruction Linked to Disability, Mortality
Patients of advanced age, black race, and with comorbidities have a higher risk of post-stroke GIBO.
Stroke Survivor Care Costs Medicare Beneficiaries $40 Billion Annually
The average annual cost for providing care to a stroke survivor was $11,300.
Idarucizumab Promising in Dabigatran-Treated Patients With ICH
REVERSE-AD is an ongoing phase 3 cohort study evaluating the reversal effects of idarucizumab on dabigatran.
MRI May Help Determine IV tPA Eligibility in Stroke of Unknown Onset
Treatment with IV tPA appeared safe and feasible with stroke onset confirmation from MRI.
Natalizumab May Improve Clinical Outcomes in Ischemic Stroke
Improvements in Rankin Scale score, Stroke Impact Scale-16, and Montreal Cognitive Assessment were observed in the treatment group.
Stenosis May Be Responsible for More Acute Ischemic Strokes
Some strokes attributable to large-artery atherosclerosis are not being recognized as such because of <50% stenosis.
Too Much, Too Little Sleep Can Increase Risk for Stroke
Those who slept more than 8 hours had a 146% greater risk of stroke.
Pioglitazone May Prevent Recurrent Stroke, Heart Attack in Patients Without Diabetes
Patients taking pioglitazone saw a 24% reduction in risk for recurrent stroke or myocardial infarction compared to placebo.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in International Stroke Conference 2016
Loading... 
Loading...